Ciba Specialty Chemicals to partner with Biosignal Ltd for antibiofilm products

Novel antibiofilm technology mimics natural defenses seen in seaweed

05-Apr-2006

Ciba specialty chemicals announced the completion of a joint development and licensing agreement with Biosignal, Sydney, Australia to develop novel antimicrobial compounds for consumer and industrial products based upon Biosignal's antibiofilm technology. Biosignal has granted Ciba Specialty Chemicals an exclusive license in some of Ciba's key markets including plastics, coatings, paints, fibres and paper products.

The formation of biofilms in many industrial environments can lead to fouling, corrosion, material degradation and general contamination. Biosignal's antibiofilm technology is based on a discovery that the eastern Australian seaweed Delisea pulchra produces natural furanones that disable bacteria's ability to colonize.

Development is expected to begin next month and testing will occur at Ciba's laboratories in Basel, Switzerland and at Biosignal's laboratories in Sydney, Australia.

Other news from the department business & finance

These products might interest you

Dursan

Dursan by SilcoTek

Innovative coating revolutionizes LC analysis

Stainless steel components with the performance of PEEK - inert, robust and cost-effective

HPLC accessories
OCA 200

OCA 200 by DataPhysics

Using contact angle meter to comprehensively characterise wetting behaviour, solids, and liquids

With its intuitive software and as a modular system, the OCA 200 answers to all customers’ needs

contact angle measuring instruments
Tailor-made products for specific applications

Tailor-made products for specific applications by IPC Process Center

Granulates and pellets - we develop and manufacture the perfect solution for you

Agglomeration of powders, pelletising of powders and fluids, coating with melts and polymers

toll manufacturing
Loading...

Most read news

More news from our other portals

Is artificial intelligence revolutionising chemistry?